Davidson Capital Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.16M Buy
9,871
+218
+2% +$128K 1.02% 26
2026
Q2
$5.11M Buy
9,653
+386
+4% +$178K 0.82% 34
2026
Q1
$4.45M Buy
9,267
+274
+3% +$140K 0.81% 41
2025
Q4
$5.05M Sell
8,993
-197
-2% -$112K 1.09% 13
2025
Q3
$4.73M Sell
9,190
-284
-3% -$124K 1.06% 10
2025
Q2
$2.97M Buy
9,474
+320
+3% +$96.1K 0.71% 47
2025
Q1
$2.79M Sell
9,154
-518
-5% -$174K 0.76% 36
2024
Q4
$3.21M Buy
9,672
+1,279
+15% +$434K 0.85% 36
2024
Q3
$2.8M Buy
8,393
+629
+8% +$239K 0.81% 40
2024
Q2
$3.2M Buy
7,764
+340
+5% +$135K 0.99% 26
2024
Q1
$3M Sell
7,424
-608
-8% -$214K 0.97% 17
2023
Q4
$2.46M Buy
+8,032
New +$2.17M 0.89% 27

Other funds holding MEDP

Davidson Capital Management's MEDP Position: Q3 2026 in Review

Davidson Capital Management increased its Medpace (MEDP) stake by 2.3% in Q3 2026, buying an estimated $128K and bringing the position to 9,871 shares worth $6.16M. The position accounts for 1.02% of the portfolio, ranked #26.

Davidson Capital Management first reported a position in MEDP in Q4 2023 and has held it in 12 quarters since. 369 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • Davidson Capital Management held 9,871 shares of Medpace worth $6.16M as of Q3 2026.
  • Davidson Capital Management bought 218 Medpace shares in Q3 2026, an estimated $128K.
  • Medpace made up 1.02% of Davidson Capital Management's portfolio in Q3 2026, its #26 holding.
  • Davidson Capital Management first reported a position in Medpace in Q4 2023 and has held it in 12 quarters since.
  • 369 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on Davidson Capital Management's 13F filing for Q3 2026, filed 15 Oct 2026.